Y/e 31 Mar( In .Cr) | Mar-2021 |
---|---|
Revenue | 1,885.16 |
yoy growth (%) | |
Raw materials | -905.49 |
As % of sales | 48.03 |
Employee costs | -149.13 |
As % of sales | 7.91 |
Other costs | -239.46 |
As % of sales (Other Cost) | 12.7 |
Operating profit | 591.07 |
OPM | 31.35 |
Depreciation | -33.39 |
Interest expense | -87.54 |
Other income | 0.81 |
Profit before tax | 470.94 |
Taxes | -119.36 |
Tax rate | -25.34 |
Minorities and other | 0 |
Adj. profit | 351.58 |
Exceptional items | 0 |
Net profit | 351.58 |
yoy growth (%) | |
NPM | 18.64 |
The drug consists of a combination of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate.
The Mumbai-based company's income from operations decreased by roughly 15% to ₹507 Crore in the three months ended September 30.
Here are some of the stocks that may see significant price movement today: ITC, Kansai Nerolac, Coromandel International, etc.
The sale will be conducted through the stock exchange mechanism, adhering to applicable legal requirements.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.